The company's inhaler devices use Electro Hydrodynamic Atomization (EHDA) technology to accurately and locally target medication in the lungs. These devices are designed to improve treatment outcomes for conditions such as asthma, lung cancer, and pulmonary arterial hypertension. Gilbert Technologies aims to enhance patient adherence and expand access to healthcare through their sustainable and socially responsible initiatives in the healthcare industry.